V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160015112 | 160007478 | 1.58 | 75.5 | Curative (C) | 2019-06-06 | 2019-07-10 | DOXORUBICIN | 01 | N | CARBOPLATIN + PACLITAXEL | 100910075 |
| 160015113 | 160007479 | 1.68 | 132 | Curative (C) | 2016-02-11 | 2016-02-26 | Cisplatin + Pemetrexed | 02 | Y | CISPLATIN + PEMETREXED | 101699647 |
| 160015114 | 160007480 | 1.72 | 87.1 | Palliative (P) | 2013-07-19 | 2013-07-21 | null | 02 | N | CARBOPLATIN + PACLITAXEL | 101864190 |
| 160015115 | 160007481 | 1.75 | 103 | Curative (C) | 2017-02-27 | 2017-03-09 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101078124 |
| 160015117 | 160007482 | 1.62 | 74.3 | 03 | 2016-02-18 | 2016-02-19 | null | 02 | N | DOXORUBICIN + OLARATUMAB | 101705982 |
| 160015119 | 160007483 | 1.8 | 61 | Palliative (P) | 2017-10-23 | 2017-11-09 | Cisplatin + Pemetrexed | N | null | CISPLATIN + PEMETREXED | 101564654 |
| 160015120 | 160007484 | 1.82 | 85 | Curative (C) | 2016-12-17 | 2016-12-19 | DOXORUBICIN | N | N | EW EUROEWING 2012 ARM B VDC | 100988894 |
| 160015122 | 160007485 | 1.59 | 61 | Neo-adjuvant (N) | 2017-10-23 | 2017-11-02 | Trial Unspecified | 02 | N | IFOSFAMIDE + LIPOSOMAL DOXORUBICIN | 100759835 |
| 160015124 | 160007486 | 1.88 | 73.8 | Palliative (P) | 2018-06-20 | 2018-06-24 | Cisplatin + Pemetrexed | 2 | null | CISPLATIN + PEMETREXED | 100229385 |
| 160015125 | 160007487 | 1.69 | 51.4 | Neo-adjuvant (N) | 2019-03-23 | 2019-04-06 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN | 101461802 |
| 160015128 | 160007488 | 1.83 | 55.9 | Palliative (P) | 2017-11-28 | 2017-12-26 | Doxorubicin 75mg/m2 | 02 | N | PACLITAXEL | 100404490 |
| 160015137 | 160007489 | 1.75 | 60 | Palliative (P) | 2019-03-18 | 2019-03-18 | Cisplatin + Pemetrexed | 2 | N | CISPLATIN + PEMETREXED | 101854820 |
| 160015139 | 160007490 | 1.84 | 70.1 | Palliative (P) | 2016-04-28 | 2016-05-01 | NB Low/Interm risk guidelines Carbo/Etop | 02 | N | IPILIMUMAB + NIVOLUMAB | 101142357 |
| 160015141 | 160007491 | 1.8 | 77.6 | Palliative (P) | 2016-08-07 | 2016-08-07 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101229304 |
| 160015142 | 160007492 | 1.64 | 72 | Palliative (P) | null | 2017-08-06 | Doxorubicin + Ifosfamide | null | null | DOXORUBICIN + IFOSFAMIDE | 100888297 |
| 160015144 | 160007493 | 0 | 8.9 | Palliative (P) | 2019-07-09 | 2019-07-10 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101787897 |
| 160015145 | 160007494 | 1.76 | 82 | Neo-adjuvant (N) | 2018-02-12 | 2018-02-12 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101348719 |
| 160015146 | 160007495 | 1.51 | 69.2 | Palliative (P) | 2019-08-23 | 2019-09-25 | Trial Unspecified | 02 | null | CARBOPLATIN + PACLITAXEL | 100154359 |
| 160015147 | 160007496 | 0 | 99 | Palliative (P) | 2019-06-20 | 2019-07-07 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 101445670 |
| 160015149 | 160007497 | 1.65 | 75 | null | 2019-02-23 | 2019-03-09 | CARBOPLATIN + PACLITAXEL | N | N | CARBOPLATIN + PACLITAXEL | 100577020 |
| 160015150 | 160007498 | 1.8 | 77 | Palliative (P) | 2018-04-03 | 2018-04-18 | Liposomal Doxorubicin (Caelyx) | 02 | null | ETOP 13-18 BEAT-MESO TRIAL | 100560000 |
| 160015151 | 160007499 | 1.79 | 65.25 | null | 2016-12-05 | 2016-12-13 | Etoposide + Ifosfamide (3 days) | 02 | N | IMATINIB | 101589026 |
| 160015152 | 160007500 | 1.6 | 55.2 | Palliative (P) | 2020-11-10 | 2020-11-23 | Vinorelbine IV | 01 | N | DOXORUBICIN + IFOSFAMIDE | 100129396 |
| 160015156 | 160007501 | 1.55 | 107.9 | null | 2015-06-11 | 2015-07-09 | Olaparib | 02 | 2 | STS RHABDOMYOSARCOMA RMS 2005 IVAVV | 100211062 |
| 160015158 | 160007502 | 1.57 | 89.2 | Adjuvant (A) | null | 2020-01-18 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 101342779 |
| 160015159 | 160007503 | null | 72.2 | Neo-adjuvant (N) | 2017-03-10 | 2017-03-20 | VINORELBINE | null | null | VIDE | 101100595 |
| 160015160 | 160007504 | 1.71 | 97.7 | Palliative (P) | 2022-04-04 | 2022-04-18 | Carboplatin + Paclitaxel (3 weekly) | N | N | CARBOPLATIN + PACLITAXEL | 101103777 |
| 160015161 | 160007505 | null | null | Palliative (P) | 2018-12-15 | 2018-12-22 | Pazopanib | 02 | null | DOXORUBICIN + IFOSFAMIDE | 101190421 |
| 160015162 | 160007506 | 1.78 | 70 | Palliative (P) | 2018-09-23 | 2018-09-24 | Liposomal Doxorubicin (Caelyx) | N | null | TRIAL UNSPECIFIED | 100403623 |
| 160015165 | 160007507 | 1.63 | 91 | Neo-adjuvant (N) | 2019-04-26 | 2019-04-27 | Doxorubicin + Ifosfamide | 02 | N | LIPOSOMAL DOXORUBICIN | 101793642 |
| 160015166 | 160007508 | 1.6 | 66 | Curative (C) | 2017-03-24 | 2017-04-07 | GemCarbo Days 1+8 | 02 | N | CISPLATIN + PEMETREXED | 100436142 |
| 160015167 | 160007509 | null | null | null | 2018-06-24 | 2018-06-28 | Doxorubicin + Ifosfamide | 02 | null | TRIAL UNSPECIFIED | 100548178 |
| 160015170 | 160007510 | 1.78 | 82.7 | Palliative (P) | 2018-10-01 | 2018-10-13 | Liposomal Doxorubicin (Caelyx) | 02 | null | DOXORUBICIN + OLARATUMAB | 100871743 |
| 160015171 | 160007511 | 1.78 | 76.7 | Neo-adjuvant (N) | 2016-12-06 | 2017-01-01 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100713044 |
| 160015172 | 160007512 | 1.85 | 95.7 | Curative (C) | 2016-07-11 | 2016-08-01 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 100956053 |
| 160015179 | 160007513 | 1.7 | 74.6 | Curative (C) | 2018-01-05 | 2018-01-15 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100544312 |
| 160015180 | 160007514 | 1.54 | 74.8 | Palliative (P) | 2018-07-29 | 2018-07-29 | CARBOPLATIN + PACLITAXEL | 02 | N | CARBOPLATIN + PACLITAXEL | 101564116 |
| 160015182 | 160007515 | 1.73 | 68.5 | Palliative (P) | 2019-10-21 | 2019-11-11 | Trial Unspecified | N | N | TRIAL UNSPECIFIED | 101582783 |
| 160015183 | 160007516 | 1.69 | 57 | Palliative (P) | null | 2019-02-21 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100204205 |
| 160015185 | 160007517 | 1.78 | 70.9 | Palliative (P) | 2017-05-27 | 2017-06-01 | Abiraterone | 02 | N | VIDE | 100383522 |
| 160015186 | 160007518 | 1.75 | 79.5 | Palliative (P) | 2018-09-07 | 2018-09-10 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | CISPLATIN + GEMCITABINE | 100010714 |
| 160015187 | 160007519 | 1.71 | 79 | Palliative (P) | 2018-10-24 | 2018-10-24 | Doxorubicin 75mg/m2 | N | null | DOXORUBICIN | 101045720 |
| 160015190 | 160007520 | 1.8 | 52 | Palliative (P) | 2018-07-24 | 2018-09-15 | Liposomal Doxorubicin (Caelyx) | 02 | N | CARBOPLATIN + PACLITAXEL | 101594427 |
| 160015194 | 160007521 | 1.8 | 73.9 | Palliative (P) | 2017-04-09 | 2017-04-09 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100725628 |
| 160015195 | 160007522 | 1.65 | 60.2 | Palliative (P) | 2017-04-17 | 2017-04-27 | DOXORUBICIN + IFOSFAMIDE | N | N | PAZOPANIB | 101550319 |
| 160015196 | 160007523 | null | null | null | 2018-12-10 | 2018-12-11 | Doxorubicin + Ifosfamide | N | N | DOXORUBICIN + OLARATUMAB | 101212714 |
| 160015200 | 160007525 | 1.83 | 72 | Palliative (P) | 2019-05-28 | 2019-05-28 | Bevacizumab 7.5mg/kg | null | null | IVA | 101413559 |
| 160015201 | 160007526 | 1.82 | 77.9 | null | 2018-06-22 | 2018-06-23 | VAC | 02 | null | TRIAL UNSPECIFIED | 100436238 |
| 160015203 | 160007527 | 1.71 | 54.6 | Palliative (P) | 2018-04-16 | 2018-04-16 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 101689255 |
| 160015206 | 160007528 | null | 39.7 | null | 2018-03-18 | 2018-03-31 | VIDE | 02 | null | TRABECTEDIN | 100739073 |